Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study

Table 4

Association between use of a DPP-4 inhibitor and a beta blocker.

Agent		Beta blocker
		Yes	No
Sitagliptin	257	86 (33.5%)	171 (66.5%)
Vildagliptin	42	7 (16.6%)	35 (83.4%)

Chi square = 4.001, df = 1, = 0.045.